Will Micron Technology Stock Soar to $1,500 After Sept. 30?

Micron is expected to report fiscal Q4 revenue of about $50.0B, up 341% year over year, and EPS of $30.73, up 985%, after fiscal Q3 revenue rose 346% to $41.4B and EPS surged 1,368% to $24.67. HBM supply shortages and Micron's HBM4 shipments are supporting pricing power, but the stock remains 19% below its June high amid concerns that rising AI deployment costs could curb future GPU and memory demand. Wall Street expects a $56.6B fiscal Q1 2027 sales outlook and $155.03 in fiscal 2027 EPS, though eventual memory-capacity expansion could erode margins and pricing power.

Analysis

MU’s near-term earnings setup is less about reported upside than the durability of fiscal-2027 pricing assumptions embedded in consensus. HBM is capacity-constrained by packaging, yields, and qualification cycles rather than wafer capacity alone, so a modest beat can sustain pricing longer than the broader DRAM cycle; however, the stock’s low apparent forward multiple is a peak-earnings discount, not necessarily a valuation anomaly. The critical Sept. 30 datapoints are HBM revenue mix, gross-margin trajectory, contracted pricing/volume visibility, and whether management commits to incremental supply expansion.

The non-obvious offset to enterprise AI cost controls is that model efficiency can reduce total GPU-hours while increasing memory intensity per deployed accelerator and shifting demand toward inference systems. That is relatively favorable for MU versus a pure compute-exposure thesis, particularly if Rubin-class platforms require higher HBM content. Conversely, any hyperscaler capex moderation would hit NVDA system demand first but could affect MU with a lag as customers work through qualified HBM inventory; the market is likely underpricing that lagged inventory/pricing risk over 6-18 months.

Competitive risk is asymmetric: SK Hynix and Samsung can pressure MU’s share and pricing if HBM4 yields normalize faster than expected, while broader memory supply additions can collapse commodity DRAM/NAND margins even if HBM remains tight. The immediate catalyst is guidance; the 1-3 month catalyst path is customer commentary from MSFT, AMZN and NVDA on AI monetization and capex. A sustained downward revision to MU’s fiscal-2027 EPS, weaker gross margin, or evidence of HBM supply easing would invalidate the bullish case.

Key Decisions for Investors

• Maintain a tactical long MU only through Sept. 30 with defined risk: use a 1-3 month call spread rather than unhedged equity if implied volatility permits. The thesis requires a guidance raise plus stable/improving gross-margin outlook; exit on guidance that merely reiterates consensus or any indication of HBM qualification/yield slippage.
• Prefer a relative-value long MU / short SOXX position over a broad semiconductor long for the next 1-3 months. MU has the clearest potential pricing upside, while SOXX carries more exposure to AI-capex disappointment; size modestly because a broad risk-off move can overwhelm the spread.
• Do not underwrite the cited forward earnings multiple as a standalone long signal. Set an alert for fiscal-2027 consensus EPS revisions: a decline of more than 10% following results would indicate the market is beginning to price memory-cycle normalization and should trigger reduction of long exposure.
• Watch NVDA, MSFT and AMZN earnings/commentary for AI infrastructure utilization and capex revisions over the next two reporting cycles. A capex cut is a hedge trigger for MU longs; an acceleration in Rubin deployment or HBM content guidance supports adding after earnings rather than chasing the event.